Abstract:The best hope for slowing the progression of Alzheimer's disease (AD) will necessitate identifying sensitive biomarkers that precede and predict future symptomatic onset, i.e., amnestic Mild Cognitive Impairment (aMCI). We previously developed surface multivariate tensor-based morphometry (mTBM) and grey matter morphology signatures as potential structural MRI AD biomarkers to study hippocampal and lateral ventricular morphology. We subsequently developed patch-based sparse coding algorithms to successfully extract the most discriminating features from MR images for predicting cognitive decline. We now use these methods on a sample balanced for APOE gene dose. From a prospective cohort study, 18 initially cognitively unimpaired adults who subsequently progressed to the clinical diagnosis of aMCI or dementia due to AD within 1.8±0.8 years (progressors) were matched for age, sex, education, and APOE4 gene dose to 20 adults who remained cognitively unimpaired for at least 4 years after baseline visits (nonprogressors). Each baseline MRI scan was segmented with FSL (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki), the hippocampal and ventricle surfaces parameterized, and the surface multivariate morphometry statistics (MMS) consisting of mTBM and radial distance (RD) generated. A collection of overlapping patches on the surface as the initial sparse coding dictionary was constructed. Stochastic Coordinate Coding was then applied to learn a dictionary and sparse codes. The max-pooling algorithm on the newly learned high-dimensional features was used to obtain a final set of low-dimensional features. Finally, an AdaBoost classifier was applied to categorize aMCI and cognitively unimpaired individuals with 5-fold cross validation adopted to evaluate classification accuracy, sensitivity, specificity, positive and negative predictive values. The prediction result of aMCI/AD was achieved with hippocampal surface MMS features, with 100% accuracy, 100% sensitivity, 100% specificity, 100% positive and 100% negative predictive values. This compares to 79% sensitivity and 78% specificity in the same sample based on standard automated brain mapping algorithmic programs to measure hippocampal volume, and assessed via binary logistic regression, and leave-one-out procedures. While our findings should be considered preliminary, sparse coding together with the surface multivariate morphometry may be applied to individual volumetric MRIs to predict imminent progression from the preclinical to clinical stages of AD with great accuracy.

An Improved Strategy for Predicting Alzheimer's Disease Progression in Patients with Mild Cognitive Impairment by Clustering Hippocampal Shape Data

A Novel Cascade Machine Learning Pipeline for Alzheimer’s Disease Identification and Prediction

Hippocampal shape analysis of Alzheimer disease based on machine learning methods.

Hippocampus Analysis by Combination of 3-D DenseNet and Shapes for Alzheimer's Disease Diagnosis

Prediction and clustering of Alzheimer's disease by race and sex: a multi-head deep-learning approach to analyze irregular and heterogeneous data

Morphometric Analysis of Hippocampus and Lateral Ventricle Reveals Regional Difference Between Cognitively Stable and Declining Persons

A Surface-Based Federated Chow Test Model for Integrating APOE Status, Tau Deposition Measure, and Hippocampal Surface Morphometry

Hyperbolic Space Sparse Coding with Its Application on Prediction of Alzheimer's Disease in Mild Cognitive Impairment.

Hippocampus Morphometry Study on Pathology-Confirmed Alzheimer's Disease Patients with Surface Multivariate Morphometry Statistics

Hippocampal shape and asymmetry analysis by cascaded convolutional neural networks for Alzheimer’s disease diagnosis

Multi-resolution 3D-HOG feature learning method for Alzheimer’s Disease diagnosis

Isometry Invariant Shape Descriptors for Abnormality Detection on Brain Surfaces Affected by Alzheimer’s Disease

Research on Pathogenic Hippocampal Voxel Detection in Alzheimer's Disease Using Clustering Genetic Random Forest

Probabilistic Clustering using Shared Latent Variable Model for Assessing Alzheimers Disease Biomarkers

APPLYING SPARSE CODING TO SURFACE MULTIVARIATE TENSOR-BASED MORPHOMETRY TO PREDICT FUTURE COGNITIVE DECLINE.

Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding

Improved Prediction of Beta-Amyloid and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding

Characterizing the clinical heterogeneity of early symptomatic Alzheimer's disease: a data-driven machine learning approach

IMPROVED PREDICTION OF PROGRESSION TO CLINICAL STAGES OF ALZHEIMER’S DISEASE USING MULTIVARIATE SURFACE MORPHOMETRY OF MRI BIOMARKERS AND PATCH-BASED SPARSE CODING

Automatic Discrimination of Alzheimer's Disease from Normal Aging Based on MRI Hippocampal Shape Analysis

Predicting Future Cognitive Decline with Hyperbolic Stochastic Coding